Electrophysiologic Effects of a Class I Antiarrhythmic Agent, Cibenzoline, on the Refractoriness and Conduction of the Human Atrium In Vivo
Authors:
- Akihiko ShimizuASAkihiko Shimizu
- Yeong-Hwa ChunYCYeong-Hwa Chun
- Hironari TatsunoHTHironari Tatsuno
- Toshihiko YamagataTYToshihiko Yamagata
- Masunori MatsuzakiMMMasunori Matsuzaki
- 1 August 1996
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 28 (2) , 321-327
Abstract
We investigated the effects of a class I antiarrhythmic drug, cibenzoline, on human atrial muscle in vivo. Electrophysiologic measurements were performed in 44 patients (mean age 49 +/- 15 years), before and after an intravenous infusion of cibenzoline 1.4 mg/kg in 5 min. Extrastimuli at a basic cycle length (BCL) of 500 ms were delivered from the right atrial appendage. The effective refractory period of the right atrium (ERP-A), the conduction time from the high right atrium to the coronary sinus, maximum conduction delay (Max. CD), repetitive atrial firing zone (RAFZ), fragmented atrial activity zone (FAAZ), and conduction delay zone (CDZ) were measured. Patients were divided into two groups according to whether repetitive atrial firing (RAF) was induced (group A, n = 18) or not (group B, n = 26). Cibenzoline increased ERP-A from 198 +/- 25 to 214 +/- 26 ms (p < 0.05) and decreased Max. CD from 55 +/- 23 to 43 +/- 19 ms (p < 0.05). There were significant decreases in the RAFZ (10 +/- 17 to 4 +/- 10 ms, p < 0.05), the FAAZ (20 +/- 25 to 12 +/- 18, ms p < 0.05), and the CDZ (41 +/- 21 to 32 +/- 19 ms, p < 0.05). Cibenzoline significantly increased ERP.A (186 +/- 25 to 212 +/- 26 ms, p < 0.05) in group A, but not in group B. There were significant decreases in the RAFZ [25 +/- 19 to 9 +/- 15 ms (p < 0.05) and FAAZ 22 +/- 29 to 11 +/- 21 ms, (p < 0.05)] in group A, but not in group B. The results suggest that cibenzoline can suppress paroxysmal atrial fibrillation by prolongation of ERP-A and may also have preferential effects on the substrate of atrial fibrillation and RAF.Keywords
This publication has 36 references indexed in Scilit:
- Repetitive Atrial Firing and Fragmented Atrial Activity Elicited by Extrastimuli in the Sick Sinus Syndrome With and Without Abnormal Atrial ElectrogramsThe American Journal of the Medical Sciences, 1994
- Electrophysiological Abnormalities of the Atrial Muscle in Patients with Manifest Wolff‐Parkinson‐White Syndrome Associated with Paroxysmal Atrial FibrillationPacing and Clinical Electrophysiology, 1992
- Electrophysiological properties in chronic lone atrial fibrillation.Circulation, 1991
- Prolonged and fractionated right atrial electrograms during sinus rhythm in patients with paroxysmal atrial fibrillation and sick sinus node syndromeJACC, 1991
- Intra-atrial conduction delay and fragmented atrial activity in patients with paroxysmal atrial fibrillation.Japanese Circulation Journal, 1989
- Inhibition of the myocardial Ca2+ inward current by the class 1 antiarrhythmic agent, cibenzolineBritish Journal of Pharmacology, 1986
- Pharmacological mapping of regional effects in the rabbit heart of some new antiarrhythmic drugsBritish Journal of Pharmacology, 1983
- EFFECTS ON RABBIT NODAL, ATRIAL, VENTRICULAR AND PURKINJE CELL POTENTIALS OF A NEW ANTIARRHYTHMIC DRUG, CIBENZOLINE, WHICH PROTECTS AGAINST ACTION POTENTIAL SHORTENING IN HYPOXIABritish Journal of Pharmacology, 1982
- Effects of cycle length on atrial vulnerability.Circulation, 1977
- Circus movement in rabbit atrial muscle as a mechanism of tachycardia. II. The role of nonuniform recovery of excitability in the occurrence of unidirectional block, as studied with multiple microelectrodes.Circulation Research, 1976